Skip to main content

Together we are beating cancer

Donate now

In depth

Showing 12 out of 199 results
Andrea receiving chemotherapy.

Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that. Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that.

by Tim Gunn | In depth | 22 May 2023

22 May 2023

Bowel cancer cells under the microscope

FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again.  FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again. 

by Jacob Smith | In depth | 25 April 2023

25 April 2023

Lab equipment at our Experimental Cancer Medicine Centre in Southampton
  • Science & Technology
  • Health & Medicine

3 ways we're helping teenagers and young adults with cancer

Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them. Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them.

by Tim Gunn | In depth | 18 April 2023

18 April 2023

A scientist handling patient samples at an experimental cancer medicine centre.

We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people. We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.

by Tim Gunn | In depth | 3 April 2023

3 April 2023

We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…    We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…   

by Phil Prime | In depth | 10 March 2023

10 March 2023

Two of our Cancer Awareness Nurses at a stop of our Cancer Awareness Roadshow

Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions. Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions.

by Sophie Marshall | In depth | 2 March 2023

2 March 2023

A cancer cell undergoing mitosis, or cloning itself and splitting in two.

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it. Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it.

by Tim Gunn | In depth | 20 February 2023

20 February 2023

We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily. We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily.

by Cancer Research UK | In depth | 10 February 2023

10 February 2023

Restricting cancer cells of specific amino acids can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets which can enhance cancer treatments. Restricting cancer cells of specific amino acids can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets which can enhance cancer treatments.

by Cancer Research UK | In depth | 30 January 2023

30 January 2023

Headshots of Dame Valerie Beral, Anne Szarewski, Nandita deSouza and Yvonne Barr

As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more. As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

by Amy Warnock | In depth | 25 January 2023

25 January 2023

A busy London street.

Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around. Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around.

by Tim Gunn | In depth | 24 January 2023

24 January 2023

Headshots of Ruth Plummer, Eve Wiltshaw and Judith Bliss

As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more. As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

by Amy Warnock | In depth | 18 January 2023

18 January 2023